Novartis AG
People also watch:GSKSNYAZNLLYABT
82.08-0.81 (-0.98%)

After hours: 82.090.01 (0.01%) as of 5:16 PM EDT

Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Prev Close82.89
Bid82.07 x 400
Ask82.08 x 1100
52wk Range69.90 - 104.75
Day's Range81.57 - 82.58
Avg Vol (3m)1,809,768
As of 4:02 PM EDT. Market closed.
  • TheStreet.com6 hours ago

    AstraZeneca (AZN) Stock Up After Q2 Earnings, Revenue Beat

    AstraZeneca (AZN) stock is increasing this afternoon after the company reported better-than-expected results before today's market open.

  • Reuters11 hours ago

    AstraZeneca a bid target again? CEO says someone may spot value

    AstraZeneca's chief executive believes a rival could spot the growing value of its drug pipeline but declined to say if the group was likely to be a takeover target once more, two years after seeing off a bid from Pfizer. This time speculation has moved to the idea of a possible offer from Swiss-based Novartis, which would increase its cancer drug operations significantly by acquiring its smaller British rival. Citi analyst Andrew Baum suggested in a note this week that AstraZeneca's biotech expertise and advanced immunotherapy cancer pipeline made it an attractive target for the Basel-based group.